2.37 USD
▲-0.03+1.28%
盘后 2.38 +1.71%
2026-08-03
市值
$304.96M
市盈率
—
EPS
-0.12
股息率
—
52 周区间
2.04 – 7.08
成交量
831.55K
Beta
1.33
目标价
3.00
52W 低 2.0452W 高 7.08
价格走势
公司简介
Organogenesis Holdings Inc., a regenerative medicine company, develops, manufactures, and commercializes products for the advanced wound care, and surgical and sports medicine markets in the United States. Its advanced wound care products include Affinity and Novachor, which are amnion and chorion placental allografts for use in the care of chronic and acute wounds as protective barriers and extracellular matrix (ECM) scaffolds; Apligraf, a bioengineered bi-layered skin substitute for the treatment of venous leg ulcers and diabetic foot ulcers ...